Summary
The α-adrenergic agonist, clonidine, causes sedation in normal rats. The present study demonstrates that clonidine evokes strong locomotor stimulation in rats pretreated with 6-hydroxydopamine plus reserpine. Similar, but less intensive hyperactivity is observed in rats given clonidine after combined pretreatment with 6-hydroxydopamine plus p-chlorophenylalanine plus α-methyl-p-tyrosine, or with reserpine plus low doses of yohimbine. The α-adrenolytic drugs, phenoxybenzamine, phentolamine and aceperone, as well as high doses of yohimbine, antagonise the clonidine-induced locomotor stimulation; in contrast, the dopamine receptor blocking agents, pimozide and spiroperidol, exert no antagonistic effect. The results indicate that in the brain of normal animals, clonidine predominantly activates presynaptic α-adrenoceptors on noradrenergic neurones and thereby induces sedation. After destruction of the noradrenergic fibres by 6-hydroxydopamine plus reserpine, activation of postsynaptic α-adrenoceptors prevails so that hyperactivity results.
Similar content being viewed by others
References
Andén, N. E., Strömbom, U.: Adrenergic receptor blocking agents: Effects on central noradrenaline and dopamine receptors and on motor activity. Psychopharmacologia (Berl.) 38, 91–103 (1974)
Andén, N. E., Corrodi, H., Fuxe, K., Hökfelt, B., Höhfelt, T., Rydin, C., Svensson, T.: Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci. 9, 513–523 (1970)
Andén, N. E., Strömbom, U., Svensson, T. H.: Dopamine and noradrenaline receptor stimulation: Reversal of reserpine-induced suppression of motor activity. Psychopharmacologia (Berl.) 29, 289–298 (1973)
Andén, N. E., Grabowska, M., Strömbom, U.: Different alphaadrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 43–52 (1976)
Breese, G. R., Traylor, T. D.: Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: Evidence for selective degeneration of catecholoamine neurons. J. Pharmacol. exp. Ther. 174, 413–420 (1970)
Breese, G. R., Cooper, B. R., Mueller, R. A.: Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine. Brit. J. Pharmacol. 52, 307–314 (1974)
Connon, E., Wyatt, R. J., Gillin, J. C.: Potentiation of amphetamine-induced hyperactivity by acute but not chronic parachlorophenylalanine treatment in the rat. Life Sci. 18, 763–768 (1976)
Corrodi, H., Fuxe, K., Kjungdahl, A., Ögren, S. O.: Studies on the action of some psychoactive drugs on central noradrenaline neurones after inhibition of dopamine-β-hydroxylase. Brain Res. 24, 451–470 (1970)
Costall, B., Naylor, R. J.: On the mode of action of apomorphine. Europ. J. Pharmacol. 21, 350–361 (1973)
Delbarre, B., Schmitt, H.: Sedative effects of α-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs. Europ. J. Pharmacol. 13, 356–363 (1971)
Delbarre, B., Schmitt, H.: A further attempt to characterize sedative receptors activated by clonidine in chickens and mice. Europ. J. Pharmacol. 22, 355–359 (1973)
Dunstan, R., Jackson, D. M.: The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol. Psychopharmacology 48, 105–114 (1976)
Finch, L., Buckingham, R. E., Moore, R. A., Bucher, T. J.: Evidence for a central α-sympathomimetic action of clonidine in the rat. J. Pharm. Pharmacol. 27, 181–186 (1975)
Florio, V., Bianchi, L., Longo, V. G.: A study of the central effects of sympathomimetic drugs: EEG and behavioural investigations on clonidine and naphazoline. Neuopharmacology 14, 707–714 (1975)
Laverty, R., Taylor, K. M.: Behavioural and biochemical effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) on the central nervous system. Brit. J. Pharmacol. 35, 253–264 (1969)
Lloyd, K. G., Bartholini, G.: The effect of methiothepin on cerebral monoamine neurons. In: Serotonin — New vistas, histochemistry and pharmacology, advances in biochemical psychopharmacology, vol. 10 (E. Costa, G. L. Gessa, and M. Sandler, eds.), pp. 305–309. New York: Raven Press 1974
Mabry, P. D., Campbell, B. A.: Serotoninergic inhibition of catecholamine-induced behavioural arousal. Brain Res. 49, 381–391 (1973)
Maj, J., Grabowska, M., Mogilnicka, E.: The effect of l-DOPA on brain catecholamines and motility in rats. Psychopharmacologia (Berl.) 22, 162–171 (1971)
Maj, J., Sowińska, H., Baran, L., Kapturkiewicz, Z.: The effect of clonidine on locomotor activity in mice. Life Sci. 11, 483–491 (1972)
Maj, J., Baran, L., Grabowska, M., Sowińska, H.: Effect of clonidine on the 5-hydroxytryptamine and 5-hydroxyindoleacetic acid brain levels. Biochem. Pharmacol. 22, 2679–2683 (1973)
Malec, D., Langwiński, R., Kruszewska, A.: The role of serotonin in ephedrine-induced stereotypy and hypermotility. Arch. Immunol. Ter. exp. (Wroclaw) 24, 829–836 (1976)
Scheel-Krüger, J.: Studies of various amphetamines, apomorphine and clonidine on body temperature and brain 5-hydroxytryptamine metabolism in rats. Psychopharmacologia (Berl.) 36, 189–202 (1974)
Starke, K., Altmann, K. P.: Inhibition of adrenergic neurotransmission by clonidine: An action on prejunctional α-receptors. Neuropharmacology 12, 339–347 (1973)
Starke, K., Montel, H.: Involvement of α-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones. Neuropharmacology 12, 1073–1080 (1973)
Starke, K., Borowski, E., Endo, T.: Preferential blockade of presynaptic α-adrenoceptors by yohimbine. Europ. J. Pharmacol. 34, 385–388 (1975)
Strömbom, U.: Effects of low doses of catecholamine receptor agonists on exploration in mice. J. Neural Transm. 37, 229–235 (1975)
Strömbom, U.: Catecholamine receptor agonists. Effects on motor activity and rate of tyrosine hydroxylation in mouse brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 167–176 (1976)
Svensson, T., Waldeck, B.: On the role of brain catecholamines in motor activity: Experiments with inhibitors of synthesis and of monoamine oxidase. Psychopharmacologia (Berl.) 18, 357–365 (1970)
Svensson, T. H., Bunney, B. S., Aghajanian, G. K.: Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine. Brain Res. 92, 291–306 (1975)
Thornburg, J. E., Moore, K. E.: Supersensitivity to dopamine agonists following unilateral, 6-hydroxydopamine-induced striatal lesions in mice. J. Pharmacol. exp. Ther. 192, 42–49 (1975)
Ungerstedt, U.: Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta physiol. scand., Suppl. 367, 69–93 (1971)
Uretsky, N., Iversen, L. L.: Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain. J. Neurochem. 17, 269–278 (1970)
Żebrowska-Łupina, I.: The effect of nordrenergic receptor blocking agents on 5-hydroxytryptamine turnover in the brain of rats. Pol. J. Pharmacol. Pharm. 28, 341–347 (1976)
Żebrowska-Łupina, I., Kleinrok, Z.: Behavioural effects of yohimbine administered intraventricularly in the rat. Psychopharmacologic (Berl.) 33, 267–275 (1973)
Żebrowska-Łupina, I., Kleinrok, Z.: The effect of α-adrenolytics on the levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in rat's brain. Pol. J. Pharmacol. Pharm., Suppl. 27, 241–245 (1975)
Author information
Authors and Affiliations
Additional information
This study was supported by Polish Academy of Sciences (10.4). Preliminary accounts were presented at the Pharmacology Meeting, Hannover, September 14–17, 1976 and at the 1 st Joint Symposium of Hungarian and Polish Pharmacological Societies, Zakopane, October, 13–15, 1976
Rights and permissions
About this article
Cite this article
Żebrowska-Łupina, I., Przegaliński, E., Słoniec, M. et al. Clonidine-induced locomotor hyperactivity in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 297, 227–231 (1977). https://doi.org/10.1007/BF00509265
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00509265